Smokeless tobacco products profile and pictorial warning labels in India: A review
Fareeda B. Shaik 1  
,   Narendra Maddu 1  
More details
Hide details
Department of Biochemistry, Sri Krishnadevaraya University, Anantapur, India
Fareeda B. Shaik   

Department of Biochemistry, Sri Krishnadevaraya University, Anantapur, 515003, Andhra Pradesh, India
Submission date: 2019-01-08
Final revision date: 2019-03-27
Acceptance date: 2019-11-29
Publication date: 2019-12-19
Popul. Med. 2019;1(December):7
Smokeless tobacco (SLT) companies produce different SLT brands and types that are used extensively throughout India.

Within this cross-sectional pack-collection study, available information on details, composition, and profiles of various SLT products and the pictorial warning labels were collected from available retail paan shops in Ananthapur town, Andhra Pradesh, India.

SLT products are defined by specified names according to regional levels and the products of SLT have their own product constituents. The smokeless tobacco products like madhu chhap, hans chhap, and miraj were identified. The gutkha brands are in the form of khaleja and rebel, and are available in the Indian tobacco market. The brands of vimal, hira, rajnigandha, and RMD are panmasala products in the Ananthapur region. The health warning labels are present on the packets of most of the SLT products in the form of ‘Tobacco kills/Tobacco causes mouth cancer/ Chewing of tobacco is injurious to health/Chewing of panmasala may be injurious to health’.

This limited pack-collection study identified a plethora of SLT products on the Indian market with an array of ingredients and warning labels – including graphic warning labels. These findings suggest that the monitoring of pictorial health warnings on tobacco product packaging as prevention efforts/measures is warranted.

The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
There was no source of funding for this research.
Not commissioned; externally peer reviewed.
World Health Organization . WHO Report on the Global Tobacco Epidemic. Geneva, Switzerland: World Health Organization; 2008. Accessed March 27, 2019.
The NCD Alliance. Tobacco: A major risk factor for non-communicable diseases. Geneva, Switzerland: The NCD Alliance; 2011. Accessed March 27, 2019.
National Institutes of Health. Smokeless Tobacco Fact Sheets. In: 3rd International Conference on Smokeless Tobacco, Advancing Science and Protecting Public Health, September 22-25, 2002. http://cancercontrol.Cancer.go.... Accessed July 4, 2008.
Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res. 2008;10(12):1773-1782. doi:10.1080/14622200802443544
National Cancer Institute, Centers for Disease Control and Prevention. Smokeless tobacco and public health: A global perspective. Bethesda, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Institutes of Health, National Cancer Institute; 2014. https://cancercontrol.cancer.g.... Accessed March 27, 2019.
Mutti-Packer S, Reid JL, Thrasher JF, Romere D, Fonga GT, Gupta PC, et al. The role of negative affect and message credibility in perceived effectiveness of smokeless tobacco health warning labels in Navi Mumbai, India and Dhaka, Bangladesh: A moderated-mediation analysis. Addict Behav. 2017;73:22-29. doi:10.1016/j.addbeh.2017.04.002
Federal Trade Commission. Federal Trade Commission Smokeless tobacco report for 2014. Accessed March 27, 2019.
Elias J, Hendlin Y, Chaffee BW, Ling PM. Don’t throw smokeless tobacco users under the bus. Addict Behav. 2017;77:289-290. doi:10.1016/j.addbeh.2017.04.007
Food and Drug Administration. Tobacco product standard for N-Nitrosonornicotine level in finished smokeless tobacco products. White Oak, MA: Food and Drug Administration; 2017. Accessed March 27, 2019.
Cullen JW, Blot W, Henningfield J, Boyd G, Mecklenburg R, Massey MM. Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General. Public Health Rep. 1986;101(4):355-373. PMID:3090602.
World Health Organization, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. In: Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, Vol. 89. Lyon, France: International Agency for Research on Cancer; 2007. Accessed March 27, 2019.
Gupta PC, Ray CS. Smokeless tobacco and health in India and South Asia. Respirology. 2003;8(4):419-431. doi:10.1046/j.1440-1843.2003.00507.x
Joshi MS, Verma Y, Gautam AK, Shivgotra VK, Parmar G, Kumar S. Assessment of genetic damage among chewers of mixture containing mainly areca nut and tobacco. Asia Pac J Public Health. 2011;23(6):852-860. doi:10.1177/1010539511419838
European Commission. Health Effects of Smokeless Tobacco Products. Brussels, Belgium: Scientific Committee on Emerging and Newly Identified Health Risks; 2008. Accessed March 27, 2019.
Government of India. The Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) Act no. 34, 2003. New Delhi, India: Legislative Department, Ministry of Law and Justice, Government of India; 2003. Accessed March 27, 2019.
Adedigba MA, Aransiola J, Arobieke RI, Adewoled O, Oyelamie T. Between traditions and health: beliefs and perceptions of health effects of smokeless tobacco among selected users in Nigeria. Subt Use Misuse. 2017;53(4):565-573. doi:10.1080/10826084.2017.1349796
Agaku IT, Singh T, Rolle IV, Ayo-Yusuf OA. Exposure and response to current text-only smokeless tobacco health warnings among smokeless tobacco users aged ≥ 18 years, United States, 2012-2013. Prev Med. 2016;87:200-206. doi:10.1016/j.ypmed.2016.02.014
Klein EG, Queensberry AJ, Shoben AB, Cooper S, Ferketich AK, Berman M, et al. Health warning labels for smokeless tobacco: The impact of graphic images on attention, recall, and craving. Nicotine Tob Res. 2017;19(10):1172-1177. doi:10.1093/ntr/ntx021
Hammond D. Health warning messages on tobacco products: a review. Tob Control. 2011;20(5):327-337. doi:10.1136/tc.2010.037630
Konstantinou E, Fotopoulou F, Drosos A, et al. Tobacco-specific nitrosamines: A literature review. Food Chem Toxicol. 2018;118:198-203. doi:10.1016/j.fct.2018.05.008
Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol. 2008;9(7):667-675. doi:10.1016/s1470-2045(08)70173-6
Benowitz NL. Nicotine Addiction. N Engl J Med. 2010;362(24):2295-2303. doi:10.1056/nejmra0809890
Niaz K, Maqbool F, Khan F, Bahadar H, Ismail Hassan F, Abdollahi M. Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer. Epidemiol Health. 2017;39:e2017009. doi:10.4178/epih.e2017009
Murukutla N, Yan H, Wang S, Negi NS, Kotov A, Mullin S, Goodchild M. Cost effectiveness of a smokeless tobacco control media campaign in India. Tob Control. 2018;27(5):547-551. doi:10.1136/tobaccocontrol-2016-053564
Hawkins SS, Bach N, Baum CF. Impact of tobacco control policies on adolescent smokeless tobacco and cigar use: a difference-in-differences approach. BMC Public Health. 2018;18(1):154. doi:10.1186/s12889-018-5063-z
Huque R, Zaman MM, Huq SM, Sinha DN. Smokeless tobacco and public health in Bangladesh. Indian J Public Health. 2017;61(5):18-24. doi:10.4103/ijph.ijph_233_17
Kostova D, Dave D. Smokeless tobacco use in India: Role of prices and advertising. Soc Sci Med. 2015;138:82-90. doi:10.1016/j.socscimed.2015.05.036
Hammond SK. Global patterns of nicotine and tobacco consumption. Handb Exp Pharmacol. 2009;192:3-28. doi:10.1007/978-3-540-69248-5_1